This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Selenium Improves Glucose Regulation in Men

Posted: Sunday, April 04, 2010

In a French prospective observational study, older men with higher plasma selenium levels at baseline are less likely to have impaired fasting glucose levels or Type 2 diabetes during the subsequent 9 years. However, no such protective effect of higher baseline selenium levels is seen in older women in the study.

April is Defeat Diabetes® Month

Posted: Thursday, April 01, 2010

Defeat Diabetes Foundation Presents 30 Days of Activities to Help Prevent the Disease and its Complications

Drugs Don't Reduce Heart Problems for Diabetes Patients

Posted: Sunday, March 28, 2010

Key results from a landmark federal study are in and the results are disappointing for diabetes patients: adding drugs to drive blood pressure and blood-fats lower than current targets did not prevent heart problems, and in some cases caused harmful side effects.

FDA Approves Combined Diabetes Management System

Posted: Sunday, March 28, 2010

The FDA approved Medtronic's MiniMed Paradigm REAL-Time Revel System, a diabetes management system that combines an insulin pump with a glucose monitoring system. The system may represent the next step toward an artificial pancreas.

Potential New Anti-Inflammatory Drug for Type 2 Diabetes

Posted: Sunday, March 28, 2010

An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research.

Amitriptyline vs Pregabalin for Painful Diabetic Neuropathy

Posted: Sunday, March 28, 2010

Several effective treatments are available for painful diabetic neuropathy. The current study provides important insight into treatment choice by comparing two effective medications in patients with painful diabetic neuropathy. The results of this trial should help physicians tailor the best therapy for individual patients.

Early Treatment Doubles Chance of Success for People with Diabetes

Posted: Sunday, March 21, 2010

Results from the first study that compares failure rates of Metformin in real-world setting are out.

Postprandial Hyperglycemia and Increased Cardiovascular Risk

Posted: Sunday, March 21, 2010

Hyperglycemia is a major risk factor for both the microvascular and macrovascular complications in patients with Type 2 diabetes. This review summarizes the cardiovascular results of large outcomes trials in diabetes and presents new evidence on the role of hyperglycemia, with particular emphasis on postprandial hyperglycemia, in adverse cardiovascular outcomes in patients with Type 2 diabetes.

High Cholesterol, Diabetes Lead Drug Spending for the Elderly

Posted: Sunday, March 21, 2010

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 -- about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers.

Special Newsflash: Exenatide Once Weekly -- FDA Update

Posted: Tuesday, March 16, 2010

Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension).

In the complete response letter there are no requests for new pre-clinical or clinical trials. Requests raised in the letter primarily relate to the finalization of the product labeling with accompanying Risk Evaluation and Mitigation Strategy (REMS) and clarification of existing manufacturing processes.